News from oramed pharmaceuticals inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 10, 2014, 09:47 ET Oramed Submits Phase 2a Protocol to FDA for the Treatment of Type 1 Diabetes with its Oral Insulin Capsule

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...


Feb 04, 2014, 08:45 ET Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Oramed Pharmaceuticals, Inc.

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of...


Jan 30, 2014, 04:00 ET Oramed Announces Successful FDA Phase 2a Clinical Trial Results

 Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a developer of oral drug delivery systems, announced today results from its Phase 2a clinical...


Jan 27, 2014, 09:10 ET Oramed to Announce Results of its Phase 2a Clinical Trial for Oral Insulin on January 30th at the Tel Aviv Stock Exchange

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it will...


Jan 02, 2014, 08:20 ET Oramed Receives Patent Allowance in Israel and Australia for Platform Technology in Oral Delivery of Proteins

 Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it...


Dec 24, 2013, 21:12 ET Oramed to Raise $15,800,000 in Registered Direct Offering

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a developer of oral drug delivery systems, today announced that it has entered into definitive...


Dec 20, 2013, 07:30 ET Oramed Announces Successful Results from Ex-US Pharmacokinetic Study of its Oral Insulin for the Treatment of Type 1 Diabetes

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...


Dec 10, 2013, 10:37 ET Oramed Receives Allowance on its Core Oral GLP-1 Technology Patent in Israel

Oramed Pharmaceuticals Inc. (NASDAQCM:ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


Oct 03, 2013, 11:13 ET Oramed Granted Patents in Japan and Canada for its POD™ Technology for the Oral Delivery of Proteins

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...